drug evaluation

TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism
Stefania Canè, Jacques Van Snick, Catherine Uyttenhove, Luc Pilotte, Benoit J Van den Eynde

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e001798; DOI: 10.1136/jitc-2020-001798
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
Adrianne L Jenner, Tyler Cassidy, Katia Belaid, Marie-Claude Bourgeois-Daigneault, Morgan Craig

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e001387; DOI: 10.1136/jitc-2020-001387
Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy
Nina M. Muñoz, Malea Williams, Katherine Dixon, Crystal Dupuis, Amanda McWatters, Rony Avritscher, Soraya Zorro Manrique, Kevin McHugh, Ravi Murthy, Alda Tam, Aung Naing, Sapna P. Patel, David Leach, Jeffrey D. Hartgerink, Simon Young, Punit Prakash, Patrick Hwu, Rahul A. Sheth

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e001800; DOI: 10.1136/jitc-2020-001800
Letter to the editor: Checking the pulse of adoptive cell therapy for solid tumors. Thoughts from the abstracts submitted to the 35th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2020)
Martina Markovska, Francesco Marincola

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e002216; DOI: 10.1136/jitc-2020-002216
Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes
Javier Arranz-Nicolás, Miguel Martin-Salgado, Cristina Rodríguez-Rodríguez, Rosa Liébana, Maria C Moreno-Ortiz, Judith Leitner, Peter Steinberger, Antonia Ávila-Flores, Isabel Merida

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001521; DOI: 10.1136/jitc-2020-001521
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy
Anne Y Lai, Jessica A Sorrentino, Konstantin H Dragnev, Jared M Weiss, Taofeek K Owonikoko, Julie A Rytlewski, Jill Hood, Zhao Yang, Rajesh K Malik, Jay C Strum, Patrick J Roberts

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000847; DOI: 10.1136/jitc-2020-000847
Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B
Ana Alvarez de Cienfuegos, Lawrence H Cheung, Khalid A Mohamedali, Timothy G Whitsett, Jeffrey A Winkles, Walter N Hittelman, Michael G Rosenblum

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e001138; DOI: 10.1136/jitc-2020-001138

Log in using your username and password

Main menu

Log in using your username and password

You are here

drug evaluation